Eroxon

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Export map as:

Research this topic

Explore the main themes, entities and connections around Eroxon. Start with the topic map, then use the sections below for research and deeper semantic analysis.

Explore this topic

Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.

Mechanism of action

Glans penis Tumescence Nitric oxide Smooth muscle Corpora cavernosa

10 related topics

Development

Guildford London Stock Exchange AIM Glyceryl trinitrate Phase II

8 related topics

Composition

Water Ethanol Propylene glycol Glycerol Carbomer

7 related topics

Regulatory history

UKCA mark De Novo classification request

2 related topics

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

Available: Europe, United States, Latin America, Middle East
Current supplier: Cooper Consumer Health (Europe); Market Performance Group (United States)
Inception: April 2021; 5 years ago (2021-04) (CE mark)
Inventor: Futura Medical
Manufacturer: Futura Medical
Models made: Eroxon, Eroxon Intense

Topics to explore

Browse the full topic structure. Each item opens a new analysis centered on that subject.

Overview

Gel
Erectile dysfunction
Medical device
U.S. Food and Drug Administration Food and Drug Administration
Over the counter Over-the-counter drug
CE mark CE marking
United States
United Kingdom
Europe
Latin America
Middle East

Composition

Mechanism of action

Glans penis
Tumescence
Nitric oxide
Smooth muscle
Corpora cavernosa Corpus cavernosum penis
Phosphodiesterase type 5 inhibitors PDE5 inhibitor
Sildenafil
Tadalafil
Johns Hopkins University
University College London

Development

Guildford
London Stock Exchange
AIM Alternative Investment Market
Glyceryl trinitrate Nitroglycerin (medication)
Phase II Phase II clinical trial
The Journal of Sexual Medicine
Placebo
International Index of Erectile Function International Index of Erectile Function?action=edit&redlink=1

Clinical trials

Regulatory history

UKCA mark UKCA marking
De Novo classification request De Novo classification request?action=edit&redlink=1

Commercialisation

Reception

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

Map overview Semantic statistics

Nodes61

Edges60

Triples99

Avg. degree1.97

Density0.032787

Components1

How this topic connects Entity context

See the strongest relationship patterns around the current topic before diving into the raw triples.

Eroxon

Top relations

related to Commercialisation · 25

Eroxon → American, April, Belgium, Boots, Cooper Consumer Health, CVS Pharmacy, France, Futura, Haleon, In June, It, Italy, July, Latin America, Market Performance Group, Middle East, October, Portugal, September, Spain

related to Reception · 19

Eroxon → American, American Urological Association, Arthur Burnett, Cleveland Clinic, FDA, In, Johns Hopkins University, Korean, Men's Health, News, NYU Langone Health, Oral PDE5, Scott Lundy, Se Young Choi, Seth Cohen, Several, The, World Journal, Writing

related to Development · 18

Eroxon → British, Erectile Function, FM57, Futura, Futura Medical, GTN, Guildford, II, IIEF, III, In, International Index, London Stock Exchange AIM, MED2005, MED3000, Sexual Medicine, The, The Journal

related to history · 17

Eroxon → April, CE, Class II, Class IIb, De Novo, DEN220078, Europe, FDA, FM57, Futura, In, June, October, The, Three, UKCA, United Kingdom

related to Composition · 4

Eroxon → DermaSys, Futura Medical, It, None

related to Related products · 4

Eroxon → CE, Eroxon Intense, Futura Medical, UKCA

Available · 1

Eroxon → Europe, United States, Latin America, Middle East

Current supplier · 1

Eroxon → Cooper Consumer Health (Europe); Market Performance Group (United States)

Inception · 1

Eroxon → April 2021; 5 years ago (2021-04) (CE mark)

Inventor · 1

Eroxon → Futura Medical

Important terminology Word statistics

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

gel men futura medical tadalafil erectile united trial reported 2023 sold topical med3000 penis treatment device states europe american erection

Entity relationships Subject–Predicate–Object triples

Subject	Predicate	Object	Confidence	Src
Eroxon	Available	Europe, United States, Latin America, Middle East	1.00	infobox
Eroxon	Current supplier	Cooper Consumer Health (Europe); Market Performance Group (United States)	1.00	infobox
Eroxon	Inception	April 2021; 5 years ago (2021-04) (CE mark)	1.00	infobox
Eroxon	Inventor	Futura Medical	1.00	infobox
Eroxon	Manufacturer	Futura Medical	1.00	infobox
Eroxon	Models made	Eroxon, Eroxon Intense	1.00	infobox
Eroxon	Type	Medical device (topical gel)	1.00	infobox
Eroxon	Website	www.eroxon.com	1.00	infobox
Eroxon	is a	first topical ED treatment sold over the counter in the United States	0.90	text
sildenafil	instance of	The end point resembles the one reached by phosphodiesterase type 5 inhibitors	0.80	text
tadalafil	instance of	The end point resembles the one reached by phosphodiesterase type 5 inhibitors	0.80	text
though by a physical route	instance of	The end point resembles the one reached by phosphodiesterase type 5 inhibitors	0.80	text

Related concept clusters Concept neighborhoods

These clusters group vocabulary that occurs around closely connected concepts in the source material.

Connections between topic areas Semantic bridges

Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.

Min side: 3